Sarcoma

Showing NaN - NaN of 133

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Early Psychiatric Referral on Mental Health and Quality of Life

Recruiting
  • Sarcoma
  • +2 more
  • referral to the Memorial Sloan-Kettering Cancer Center (MSK) Department of Psychiatry and Behavioral Sciences.
  • Basking Ridge, New Jersey
  • +7 more
Nov 10, 2023

A Study of Immunotherapy Treatment in People With Sarcoma

Enrolling by invitation
  • Sarcoma
    • Basking Ridge, New Jersey
    • +6 more
    Oct 27, 2023

    Sarcoma, Merkel Cell Carcinoma Trial in United States (CRD3874)

    Recruiting
    • Sarcoma
    • Merkel Cell Carcinoma
    • Basking Ridge, New Jersey
    • +6 more
    Aug 28, 2023

    Sarcoma Trial in United States (XmAb23104)

    Recruiting
    • Sarcoma
    • XmAb23104
    • Basking Ridge, New Jersey
    • +6 more
    May 18, 2023

    Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States

    Recruiting
    • Invasive Ductal Breast Carcinoma
    • +14 more
    • Stereotactic body radiotherapy
    • Lattice Radiation Therapy
    • Basking Ridge, New Jersey
    • +6 more
    Apr 20, 2023

    Sarcoma, Epithelioid Sarcoma, Cutaneous Angiosarcoma Trial in Stanford, New York (Talimogene Laherparepvec (T-VEC),

    Recruiting
    • Sarcoma
    • +2 more
    • Stanford, California
    • +1 more
    Feb 2, 2023

    Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

    Completed
    • Ovarian Cancer
    • +7 more
    • Enapotamab vedotin (HuMax-AXL-ADC)
    • Phoenix, Arizona
    • +40 more
    Dec 12, 2022

    Genomic Structural Variation in Cancer Susceptibility

    Active, not recruiting
    • Breast Cancer
    • +5 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Dec 23, 2022

      Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

      Recruiting
      • Clinical Stage I Cutaneous Melanoma AJCC v8
      • +33 more
      • Informational Intervention
      • +4 more
      • Los Angeles, California
      • +4 more
      Dec 14, 2022

      Melanoma, Neuroblastoma, Sarcoma Trial in New York (124I-Humanized 3F8)

      Active, not recruiting
      • Melanoma
      • +2 more
      • 124I-Humanized 3F8
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Dec 1, 2022

      Sarcoma, Myxofibrosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in United States (Isolated Limb Infusion, Pembrolizumab,

      Recruiting
      • Sarcoma
      • +3 more
      • Isolated Limb Infusion
      • +2 more
      • Basking Ridge, New Jersey
      • +6 more
      Nov 21, 2022

      Renal Cell Cancer, Melanoma, Non-Small-Cell Lung Cancer Trial in Duarte, Louisville, New York (PF-07263689, Sasanlimab)

      Active, not recruiting
      • Renal Cell Cancer
      • +9 more
      • PF-07263689
      • Sasanlimab
      • Duarte, California
      • +5 more
      Nov 8, 2022

      Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1

      Active, not recruiting
      • Hepatocellular Carcinoma
      • +11 more
      • Part 1 TPST-1120
      • +3 more
      • San Francisco, California
      • +10 more
      Nov 1, 2022

      Melanoma, Ovarian Cancer, Sarcoma Trial in Italy, Portugal, United States (IGIMRT using a single dose of 24 Gy, IGIMRT 27 Gy in

      Active, not recruiting
      • Melanoma
      • +6 more
      • IGIMRT using a single dose of 24 Gy
      • IGIMRT 27 Gy in 3 fractions
      • San Francisco, California
      • +3 more
      Nov 1, 2022

      Sarcoma, Advanced Sarcoma, High Grade Sarcoma Trial in New York (DCC-3014, Avelumab)

      Active, not recruiting
      • Sarcoma
      • +6 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Oct 26, 2022

      Prostate Cancer, Bladder Cancer, NSCLC Trial in New York, Houston (NY-ESO-1 Plasmid DNA Cancer Vaccine)

      Completed
      • Prostate Cancer
      • +4 more
      • NY-ESO-1 Plasmid DNA Cancer Vaccine
      • New York, New York
      • +1 more
      Oct 3, 2022

      Sarcoma, Dedifferentiated Liposarcoma Trial in New York (Abemaciclib)

      Active, not recruiting
      • Sarcoma
      • Dedifferentiated Liposarcoma
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Aug 17, 2022

      NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

      Active, not recruiting
      • Non-Small Cell Lung Cancer
      • +12 more
      • Tucson, Arizona
      • +26 more
      Aug 1, 2022

      Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

      Terminated
      • Neoplasms
      • +27 more
      • Culver City, California
      • +28 more
      Jul 25, 2022

      MPNST, NF1, Sarcoma Trial in United States (Selumetinib)

      Not yet recruiting
      • MPNST
      • +2 more
      • Birmingham, Alabama
      • +13 more
      Jun 29, 2022

      Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

      Active, not recruiting
      • Breast Cancer
      • +10 more
      • Los Angeles, California
      • +7 more
      Jun 21, 2022

      SARCOMA Trial in New York, Houston (NKTR-214, Nivolumab)

      Active, not recruiting
      • SARCOMA
      • New York, New York
      • +1 more
      May 6, 2022

      Advanced Solid Tumors, Sarcoma Trial in United States (TP-1287)

      Recruiting
      • Advanced Solid Tumors
      • Sarcoma
      • Los Angeles, California
      • +9 more
      Apr 4, 2022